InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,825.94
(
0.05%
)
Post# of 37
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 468
Posts 26926
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: None

Monday, 06/27/2011 9:03:12 AM

Monday, June 27, 2011 9:03:12 AM

Post# of 37
7:17AM On The Wires (WIRES) :

Spectranetics (SPNC) announces the first patient enrollment in the EXCITE ISR clinical trial. The EXCITE ISR clinical trial will enroll up to 353 patients at up to 30 sites in the U.S. The primary efficacy endpoint of the trial is freedom from TLR, which will be evaluated through six months following the procedure. These results will be included in a 510k filing with the FDA.


surf's up......crikey



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up